0 results for 'Sanofi SA'
Amgen, Sanofi to Fight Over Enhanced Damages in Blockbuster Infringement Row
A Delaware federal judge has allowed Amgen Inc. to pursue enhanced damages in its patent infringement dispute with a rival drugmaker, the latest development to a case with billions of dollars on the line.Amgen, Sanofi to Fight Over Enhanced Damages in Blockbuster Infringement Row
A Delaware federal judge has allowed Amgen Inc. to pursue enhanced damages in its patent infringement dispute with a rival drugmaker, the latest development to a case with billions of dollars on the line.Permanent Injunction Granted Against Foiled Amgen Patent Challengers
Citing irreparable harm and inadequacy of money damages, a Delaware federal judge on Thursday permanently enjoined Sanofi SA and Regeneron Pharmaceuticals from selling a product that infringed on the patents of a rival drugmaker.Permanent Injunction Granted Against Foiled Amgen Patent Challengers
Citing irreparable harm and inadequacy of money damages, a Delaware federal judge on Thursday permanently enjoined Sanofi SA and Regeneron Pharmaceuticals from selling a product that infringed on the patents of a rival drugmaker.2016 in Review: Litigators of the Week, Take a Bow
A look back at the Litigator of the Week winners in 2016, including the firms and lawyers that racked up the most honors.J&J's Top IP Counsel Steps Down. Is the PTO His Next Stop?
Johnson & Johnson announced on Dec. 9 that its top in-house intellectual property lawyer, Philip Johnson, plans to step down in February.Patent Lawyers See a Surge in Brand-Name Drug Company Lawsuits
When brand-name drug companies go to court, it's usually to fight with a generic competitor. But that's changing. More than ever before, brand-name drug companies are bringing patent cases against each other. Patent litigators say the "brand vs. brand" trend is here to stay, so legal departments may need to rethink some strategies.K&L Gates Expands Shanghai Office With Linklaters Hire
Former Shanghai partner Simon Poh arrives at K&L Gates along with M&A lawyer Amigo Xie.Litigator of the Week: George Cary of Cleary Gottlieb
Dispatching a multibillion-dollar threat to Sanofi-Aventis, Cary polished off claims that the company blocked rival drugmakers from competing to sell blood thinners to hospitals nationwide.Revenue, Profit, Cash: Managing Law Firms for Success
Brought to you by Juris Ledger
Download Now
Law Firm Operational Considerations for the Corporate Transparency Act
Brought to you by Wolters Kluwer
Download Now
The Ultimate Guide to Remote Legal Work
Brought to you by Filevine
Download Now
Practical Guidance Journal: Protecting Work Product in a Generative AI World
Brought to you by LexisNexis®
Download Now